A.I. Learns to Write in DNA
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
Major financial exchanges are in active development on futures and derivatives products tied to AI tokens — the base unit of compute consumed every time a model processes a query. The framing is deliberate: AI compute as a commodity, traded alongside electricity, bandwidth, and crude oil. If it takes hold, enterprises could hedge their AI spend the way airlines hedge jet fuel.
The mechanics are still being worked out, but the logic is straightforward. AI inference costs are volatile and material for large organizations. A company running millions of queries a day has real exposure to price swings. Derivatives give them a way to lock in costs — and give speculators a way to bet on the future price of intelligence.
This is a sign that the AI economy is maturing past the venture-capital phase into genuine market infrastructure. When Wall Street starts building hedging products around a technology, it has moved from emerging to embedded. The open question is who sets the benchmark price — and which AI providers end up being the de facto crude in this new market.
All comments are reviewed before appearing. Keep it respectful.
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The Trump administration has no idea on how to handle open-source and open-weight AI models from China.
Google is consolidating AI leadership in California but the reorganization is pushing out the engineers who built its AI division